Addressing Boarding and Crowding in the Emergency Department
Summary
HR2936 (ABC-ED Act) authorizes zero new funding and remains in early committee stage with no near-term market impact. The bill expands eligibility for existing public health data modernization grants to include hospital bed capacity tracking at the state and regional level, but any fiscal effect requires separate appropriations.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR2936 authorizes zero new funding — it merely expands eligibility for existing grant programs
- 2.Bill remains in early committee stage; no fiscal impact without separate appropriations
- 3.No near-term market impact; no actionable tickers at this stage
Market Implications
No near-term market impact. The bill is a procedural authorization with zero funding at the earliest legislative stage. Retail investors should not base any trading decisions on this legislation. No tickers meet the causal chain threshold for inclusion.
Full Analysis
Market Impact Score
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
DELL FEDERAL SYSTEMS L.P: $602M Department of Veterans Affairs Contract
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $1.1B Department of Veterans Affairs Contract
American Innovation and R&D Competitiveness Act of 2025
Protecting Health Care and Lowering Costs Act of 2025
To amend the Export Control Reform Act of 2018 to provide for expedited consideration of proposals for additions to, removals from, or other modifications with respect to entities on the Entity List, and for other purposes.
ADVANCED TECHNOLOGY INTERNATIONAL: $304M Department of Health and Human Services Contract
Consolidated Appropriations Act, 2026
Stop Secret Spending Act of 2025
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Promoting Efficiency, Accountability, and Performance in Federal Contracting
This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.
Accelerating Medical Treatments for Serious Mental Illness
This executive order directs the FDA to prioritize review and facilitate 'Right to Try' access for psychedelic drugs, including ibogaine compounds, that have received Breakthrough Therapy designation for serious mental illnesses. It also allocates $50 million from HHS to support state programs advancing these treatments and mandates collaboration between HHS, FDA, VA, and the private sector to increase clinical trial participation and data sharing for these drugs. The Attorney General is further directed to expedite rescheduling reviews for approved Schedule I psychedelic substances.